caprotec's CCMS technology identifies novel co-targets of three anti-cancer drugs
Friday, 09 December 2011 02:07
Spectroscopy - Spectroscopy General
caprotec bioanalytics GmbH announced today the discovery of previously unknown specific drug-protein interactions for several anti-cancer drugs and the identification of potential novel co-targets of the drug molecules through the use of company's CCMS technology.
| < Prev | Next > |
|---|
Archived Articles & News
----------------------------------
- February, 2012
- January, 2012
- December, 2011
- November, 2011
- October, 2011
- September, 2011
- August, 2011
- July, 2011
- June, 2011
- May, 2011
- April, 2011
- March, 2011
- February, 2011
- January, 2011
- December, 2010
- November, 2010
- September, 2010
- August, 2010
- May, 2010
- April, 2010
- March, 2010
- February, 2010
- January, 2010
- December, 2009
